Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...
Shares of consumer-products company Kenvue Inc. rose the most in two months after the Wall Street Journal reported that ...
Starboard Values Investment in Kenvue Inc. Activist hedge fund Starboard Value has taken a sizeable stake in Kenvue Inc., ...
AI search startup Perplexity aims for $8B valuation in new round. UBS sells 50% interest in Swisscard to Amex - report.